AllianceBernstein’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74.3M | Sell |
523,533
-31,961
| -6% | -$4.24M | 0.02% | 478 |
|
|
2025
Q4 | $78.8M | Sell |
555,494
-62,635
| -10% | -$9.07M | 0.02% | 477 |
|
|
2025
Q3 | $86.8M | Buy |
618,129
+33,698
| +6% | +$4.57M | 0.03% | 457 |
|
|
2025
Q2 | $73.5M | Buy |
584,431
+8,259
| +1% | +$947K | 0.02% | 496 |
|
|
2025
Q1 | $63.7M | Sell |
576,172
-1,444
| -0.2% | -$183K | 0.02% | 519 |
|
|
2024
Q4 | $78.8M | Sell |
577,616
-59,298
| -9% | -$7.33M | 0.03% | 468 |
|
|
2024
Q3 | $73.4M | Buy |
636,914
+15,049
| +2% | +$2.06M | 0.02% | 501 |
|
|
2024
Q2 | $85.6M | Buy |
621,865
+461,642
| +288% | +$63.3M | 0.03% | 453 |
|
|
2024
Q1 | $22.1M | Sell |
160,223
-13,405
| -8% | -$1.83M | 0.01% | 837 |
|
|
2023
Q4 | $22.9M | Buy |
173,628
+24,868
| +17% | +$2.86M | 0.01% | 830 |
|
|
2023
Q3 | $16.7M | Buy |
148,760
+10,677
| +8% | +$1.12M | 0.01% | 909 |
|
|
2023
Q2 | $13M | Sell |
138,083
-13,266
| -9% | -$1.3M | 0.01% | 1014 |
|
|
2023
Q1 | $15.3M | Sell |
151,349
-15,512
| -9% | -$1.61M | 0.01% | 930 |
|
|
2022
Q4 | $19.9M | Buy |
166,861
+11,693
| +8% | +$1.37M | 0.01% | 831 |
|
|
2022
Q3 | $16.5M | Buy |
155,168
+6,541
| +4% | +$664K | 0.01% | 895 |
|
|
2022
Q2 | $14.5M | Sell |
148,627
-36,859
| -20% | -$3.4M | 0.01% | 971 |
|
|
2022
Q1 | $17.4M | Buy |
185,486
+21,984
| +13% | +$1.86M | 0.01% | 987 |
|
|
2021
Q4 | $13.9M | Sell |
163,502
-7,748
| -5% | -$713K | ﹤0.01% | 1093 |
|
|
2021
Q3 | $16.4M | Buy |
171,250
+18,279
| +12% | +$1.73M | 0.01% | 1018 |
|
|
2021
Q2 | $14.9M | Sell |
152,971
-5,975
| -4% | -$573K | 0.01% | 1059 |
|
|
2021
Q1 | $15.5M | Buy |
158,946
+100,678
| +173% | +$10.6M | 0.01% | 1016 |
|
|
2020
Q4 | $5.58M | Sell |
58,268
-639,914
| -92% | -$61.8M | ﹤0.01% | 1421 |
|
|
2020
Q3 | $67.1M | Sell |
698,182
-190,677
| -21% | -$22.1M | 0.04% | 460 |
|
|
2020
Q2 | $108M | Sell |
888,859
-244,961
| -22% | -$27.1M | 0.06% | 285 |
|
|
2020
Q1 | $98.1M | Sell |
1,133,820
-106,113
| -9% | -$10.4M | 0.07% | 259 |
|
|
2019
Q4 | $133M | Sell |
1,239,933
-10,702
| -0.9% | -$1.12M | 0.08% | 250 |
|
|
2019
Q3 | $113M | Buy |
1,250,635
+47,231
| +4% | +$4.41M | 0.07% | 276 |
|
|
2019
Q2 | $102M | Buy |
1,203,404
+98,945
| +9% | +$8.12M | 0.06% | 303 |
|
|
2019
Q1 | $97.3M | Buy |
1,104,459
+34,243
| +3% | +$2.86M | 0.06% | 308 |
|
|
2018
Q4 | $76.4M | Sell |
1,070,216
-37,978
| -3% | -$3.64M | 0.06% | 326 |
|
|
2018
Q3 | $136M | Sell |
1,108,194
-56,706
| -5% | -$6.43M | 0.09% | 229 |
|
|
2018
Q2 | $114M | Sell |
1,164,900
-108
| -0% | -$9.67K | 0.08% | 259 |
|
|
2018
Q1 | $96.6M | Buy |
1,165,008
+215,680
| +23% | +$18.2M | 0.07% | 298 |
|
|
2017
Q4 | $73.7M | Sell |
949,328
-56,319
| -6% | -$3.84M | 0.05% | 393 |
|
|
2017
Q3 | $61.6M | Buy |
1,005,647
+48,972
| +5% | +$2.58M | 0.05% | 429 |
|
|
2017
Q2 | $44M | Buy |
956,675
+28,660
| +3% | +$1.39M | 0.03% | 513 |
|
|
2017
Q1 | $40.2M | Sell |
928,015
-95,427
| -9% | -$4.09M | 0.03% | 522 |
|
|
2016
Q4 | $39.6M | Buy |
1,023,442
+147,393
| +17% | +$6.67M | 0.03% | 516 |
|
|
2016
Q3 | $44.4M | Sell |
876,049
-228,466
| -21% | -$11.4M | 0.04% | 482 |
|
|
2016
Q2 | $50.2M | Buy |
1,104,515
+957,289
| +650% | +$44.1M | 0.04% | 416 |
|
|
2016
Q1 | $5.82M | Buy |
147,226
+4,680
| +3% | +$186K | ﹤0.01% | 998 |
|
|
2015
Q4 | $8.06M | Sell |
142,546
-1,700
| -1% | -$86.4K | 0.01% | 911 |
|
|
2015
Q3 | $5.74M | Buy |
144,246
+100
| +0.1% | +$4.83K | ﹤0.01% | 1008 |
|
|
2015
Q2 | $6.88M | Buy |
144,146
+8,100
| +6% | +$343K | 0.01% | 987 |
|
|
2015
Q1 | $5.4M | Buy |
136,046
+10,200
| +8% | +$365K | ﹤0.01% | 1087 |
|
|
2014
Q4 | $2.81M | Hold |
125,846
| – | – | ﹤0.01% | 1478 |
|
|
2014
Q3 | $1.97M | Hold |
125,846
| – | – | ﹤0.01% | 1726 |
|
|
2014
Q2 | $1.87M | Sell |
125,846
-104
| -0.1% | -$1.47K | ﹤0.01% | 1824 |
|
|
2014
Q1 | $2.03M | Sell |
125,950
-6,964
| -5% | -$119K | ﹤0.01% | 1702 |
|
|
2013
Q4 | $1.24M | Buy |
132,914
+538
| +0.4% | +$5.25K | ﹤0.01% | 2032 |
|
|
2013
Q3 | $1.5M | Sell |
132,376
-165
| -0.1% | -$2.27K | ﹤0.01% | 1887 |
|
|
2013
Q2 | $1.77M | Buy |
+132,541
| New | +$1.63M | ﹤0.01% | 1692 |
|
Other funds holding NBIX
VPM
VCM
AllianceBernstein's NBIX Position: Q1 2026 in Review
AllianceBernstein reduced its Neurocrine Biosciences (NBIX) stake by 5.8% in Q1 2026, selling an estimated $4.24M and leaving 523,533 shares worth $74.3M. The position accounts for 0.02% of the portfolio, ranked #478.
AllianceBernstein first reported a position in NBIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $136M in Q3 2018. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.
- AllianceBernstein held 523,533 shares of Neurocrine Biosciences worth $74.3M as of Q1 2026.
- AllianceBernstein sold 31,961 Neurocrine Biosciences shares in Q1 2026, an estimated $4.24M.
- Neurocrine Biosciences made up 0.02% of AllianceBernstein's portfolio in Q1 2026, its #478 holding.
- AllianceBernstein first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Neurocrine Biosciences position peaked at $136M in Q3 2018.
- 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.